Outcome of AGM
Lincoln Pharmaceuticals Ltd has informed BSE that the 21st Annual General Meeting (AGM) of the Company was held on September 30, 2015.Further the Company has submitted to BSE a copy of Scrutinizer Report.01-10-2015
01-10-2015
Fixes Book Closure for Dividend & AGM
Lincoln Pharmaceuticals Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 26, 2015 to September 30, 2015 (both days inclusive) for the purpose of Payment of Dividend & Annual General Meeting (AGM) of the Company to be held on September 30, 2015.01-09-2015
Appointment of Whole Time Company Secretary
Lincoln Pharmaceuticals Ltd has informed BSE that the Company has appointed Mr. Bhavik P. Parikh, qualified Member of the Institute of Company Secretaries of India (ICSI) as a Whole Time Company Secretary of the Company w.e.f. August 17, 2015.20-08-2015
LPL - R&D; has developed an Extended Release Oral Suspension (Cough Syrup) brand name is NAMCOLD- DX(First Time In India)
Lincoln Pharmaceuticals Ltd, vide its letter dated August 12, 2015, has informed BSE about a Company Note titled "LPL - R&D; has developed an Extended Release Oral Suspension (Cough Syrup) brand name is NAMCOLD- DX(First Time In India)".13-08-2015
Limited Review for June 30, 2015
Lincoln Pharmaceuticals Ltd has submitted to BSE a Copy of the Limited Review Report for the period ended June 30, 2015.04-08-2015
Outcome of Board Meeting
Lincoln Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 04, 2015, has appointed Ms. Meha Patel as an Additional Director (Women Director) to be categorized as an Independent Director.04-08-2015
Financial Results for June 30, 2015
Lincoln Pharmaceuticals Ltd has informed BSE about the Financial Results for the period ended June 30, 2015.04-08-2015
Lincoln Pharmaceuticals Ltd. Acquire Stake In Lincoln Parenteral Ltd (Subsidiary Company of Lincoln Pharmaceuticals Limited)
Lincoln Pharmaceuticals Ltd, vide its letter dated July 30, 2015, has informed BSE that "Lincoln Pharmaceuticals Ltd. Acquire Stake In Lincoln Parenteral Ltd (Subsidiary Company of Lincoln Pharmaceuticals Limited)".30-07-2015
Closure of Trading Window
Lincoln Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 04, 2015 to consider and approve the quarterly un-audited financial results for the aforesaid quarter.In view of above, the trading window will remain close from the date of this letter and shall reopen after the expiry of 48 hours from the time of publication of the results.28-07-2015
Shareholding Pattern For June 30, 2015
Lincoln Pharmaceuticals Ltd has informed BSE about the Shareholding Pattern as on June 30, 2015.16-07-2015